384 related articles for article (PubMed ID: 34786930)
41. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
42. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
43. PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.
Brambilla D; Verpillot R; Le Droumaguet B; Nicolas J; Taverna M; Kóňa J; Lettiero B; Hashemi SH; De Kimpe L; Canovi M; Gobbi M; Nicolas V; Scheper W; Moghimi SM; Tvaroška I; Couvreur P; Andrieux K
ACS Nano; 2012 Jul; 6(7):5897-908. PubMed ID: 22686577
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of Aβ aggregates in Alzheimer's disease by epigallocatechin and epicatechin-3-gallate from green tea.
Chen T; Yang Y; Zhu S; Lu Y; Zhu L; Wang Y; Wang X
Bioorg Chem; 2020 Dec; 105():104382. PubMed ID: 33137558
[TBL] [Abstract][Full Text] [Related]
45. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
[TBL] [Abstract][Full Text] [Related]
46. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease.
Ghosh N; Kundu LM
Future Med Chem; 2021 Oct; 13(20):1767-1794. PubMed ID: 34498978
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
48. Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease.
Ma TJ; Gao J; Liu Y; Zhuang JH; Yin C; Li P; Mao L; Xu J; Xu YX; Li YP; Zhao ZX; Yin Y
Mini Rev Med Chem; 2018; 18(12):1035-1046. PubMed ID: 29243575
[TBL] [Abstract][Full Text] [Related]
49. Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer's related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans.
Sathya S; Shanmuganathan B; Balasubramaniam B; Balamurugan K; Devi KP
Food Chem Toxicol; 2020 Feb; 136():110962. PubMed ID: 31734340
[TBL] [Abstract][Full Text] [Related]
50. Light-triggered dissociation of self-assembled β-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex.
Son G; Lee BI; Chung YJ; Park CB
Acta Biomater; 2018 Feb; 67():147-155. PubMed ID: 29221856
[TBL] [Abstract][Full Text] [Related]
51. Amyloid binding ligands as Alzheimer's disease therapies.
Lee VM
Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800
[TBL] [Abstract][Full Text] [Related]
52.
Lerouge F; Ong E; Rositi H; Mpambani F; Berner LP; Bolbos R; Olivier C; Peyrin F; Apputukan VK; Monnereau C; Andraud C; Chaput F; Berthezène Y; Braun B; Jucker M; Åslund AK; Nyström S; Hammarström P; R Nilsson KP; Lindgren M; Wiart M; Chauveau F; Parola S
Nanomedicine (Lond); 2022 Dec; 17(29):2173-2187. PubMed ID: 36927004
[TBL] [Abstract][Full Text] [Related]
53. Hyaluronan-carnosine conjugates inhibit Aβ aggregation and toxicity.
Greco V; Naletova I; Ahmed IMM; Vaccaro S; Messina L; La Mendola D; Bellia F; Sciuto S; Satriano C; Rizzarelli E
Sci Rep; 2020 Sep; 10(1):15998. PubMed ID: 32994475
[TBL] [Abstract][Full Text] [Related]
54. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
56. Protection of Si Nanowires against A
Zhao X; Mou C; Xu J; Cui W; Shi Y; Wang Y; Luo T; Guo W; Ye J; Chen W
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731472
[TBL] [Abstract][Full Text] [Related]
57. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
58. Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis.
Zhang M; Li Y; Han C; Chu S; Yu P; Cheng W
Int J Nanomedicine; 2024; 19():4299-4317. PubMed ID: 38766654
[TBL] [Abstract][Full Text] [Related]
59. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
60. Atrial Natriuretic Peptide Associated with Cardiovascular Diseases Inhibits Amyloid-β Aggregation via Cross-Seeding.
Tang Y; Zhang D; Chang Y; Zheng J
ACS Chem Neurosci; 2023 Jan; 14(2):312-322. PubMed ID: 36577130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
